Affiliation:
1. Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
2. Department of Radiology, The First Hospital of Jilin University, Changchun, China.
Abstract
Abstract:
Epilepsy is defined as spontaneous recurrent seizures in the brain. There is increasing
evidence that inflammatory mediators and immune cells are involved in epileptic seizures. As more
research is done on inflammatory factors and immune cells in epilepsy, new targets for the treatment
of epilepsy will be revealed. The Janus kinase-signal transducer and transcriptional activator (JAK-
STAT) signaling pathway is strongly associated with many immune and inflammatory diseases, At
present, more and more studies have found that the JAK-STAT pathway is involved in the
development and development of epilepsy, indicating the JAK-STAT pathway’s potential promise as
a target in epilepsy treatment. In this review, we discuss the composition, activation, and regulation of the JAK-STAT pathway and the relationship between the JAK-STAT pathway and epilepsy. In
addition, we summarize the common clinical inhibitors of JAK and STAT that we would expect to be
used in epilepsy treatment in the future.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology,General Medicine
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献